| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.009 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |